Member Sign In
Member Sign Out
Cancer & Disease Research
Create a FREE account so you can:
Get the latest life sciences research and
industry news, delivered straight to your
inbox, for FREE.
Enter your Email Address to become a member:
Already have an account?
Sign in using your social networking account:
Sign in using your social networking
Forgot your password?
Tumor-promoting mutation linked to suppression of anticancer immune response
Mutations that support the growth of tumor cells may also inhibit T cells, preventing the immune system from responding effectively to emerging cancers, according to Harvard Medical School researchers.
Nanoparticles enhance effect of brain stimulation on stroke recovery in rats
Combining nasally administered nanoparticles and noninvasive brain stimulation improves the recovery of ischemic stroke in rats, according to researchers from Xi’an Jiaotong-Liverpool University and other universities in China.
Biotech licenses drug discovery platform from Harvard, Tufts to study complex CNS diseases
Unravel Biosciences has licensed a drug discovery platform from Harvard University and Tufts University to decode and model complex central nervous system (CNS) diseases.
CRISPR edited rat embryos reveal cause of rare pediatric neurodegenerative disease
Using CRISPR gene editing technology on rat embryos, University of Wisconsin-Madison researchers have revealed the mutation that is responsible for progressive gait abnormalities and other symptoms in human infants and young children with a rare neurodegenerative disease.
New AI tool discovers mutations linking bladder cancer to tobacco smoking
Using a new artificial intelligence (AI) tool, University of California, San Diego researchers contend they have for the first time uncovered a pattern of DNA mutations that links bladder cancer to tobacco smoking.
NIH funds repurposing of breast cancer drug against glioblastoma
The National Institutes of Health (NIH) is funding research into the repurposing of the breast cancer drug letrozole for use against the most deadly form of brain tumors.
Mutated mitochondrial microprotein linked to increased risk of Alzheimer’s
University of Southern California researchers have linked a mitochondrial DNA variant to increased risk of Alzheimer’s disease, pointing to a new way to tackle the hard-to-treat condition.
Combination therapy improves survival in mice with deadly glioblastoma
Combining an antidepressant and vascular endothelial growth factor inhibitor improves outcomes in mouse models of a hard-to-treat type of brain cancer, despite neither treatment being efficacious as a single agent, according to new research.
Boosting TERRA levels damages DNA of hard-to-kill cancer cells: study
Increasing levels of telomeric repeat-containing RNA (TERRA) damages the DNA of cancers with a particular form of replicative immortality and leads to cell death, according to Portuguese researchers who show that “anti-aging clocks” can be used to kill cancer cells.
Researchers further understanding of how circadian clock helps brain recover after injury
Children’s National Hospital researchers have found that a relatively newly discovered type of brain cell -- known as NG2-glia -- also follows a circadian rhythm, findings that potentially open new paths of investigation for the development of future traumatic brain injury therapies.
Cell & Gene Meeting on the Mesa
Carlsbad, California United States
American Association of Pharmaceutical Scientists PharmSci 360 Annual Meeting
Boston, Massachusetts United States
District of Columbia United States
American Society of Human Genetics Annual Meeting
Los Angeles, California United States
International Society for Pharmaceutical Engineering Annual Meeting
October 30 - November 2
Orlando, Florida United States
More Conferences »»
Building a better brain model provides window into autism
Scientists identify gene responsible for small cell lung cancer
Blood cancer drug halts bladder cancer growth: study
Certain protein implicated in Crohn's disease, points to new therapies
Scientists identify new therapeutic target for incurable glioblastoma
More articles »
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Tweets by @ScienceBoard